Amundi’s CareDx CDNA Stock Holding History

Amundi’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Hold	11,891	–	–	﹤0.01%	1804
2026 Q1	$206K	Buy	+11,891	New	+$225K	﹤0.01%	1873
2025 Q2	–	Sell	-98	Closed	-$1.7K	–	1743
2025 Q1	$1.7K	Buy	+98	New	+$2.11K	﹤0.01%	1976

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi's CDNA Position: Q2 2026 in Review

Amundi held its CareDx (CDNA) position steady in Q2 2026 at 11,891 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1804.

Amundi first reported a position in CDNA in Q1 2025 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Amundi held 11,891 shares of CareDx worth $339K as of Q2 2026.
Amundi left its CareDx share count unchanged in Q2 2026.
CareDx made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1804 holding.
Amundi first reported a position in CareDx in Q1 2025 and has held it in 3 quarters since.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.